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Antigen detection in vivo after immunization with 
different presentation forms of rabies virus 
antigen: involvement of marginal met allophilic 
macrophages in the uptake of immune-stimulating 
complexes 
Several mechanisms have been postulated to explain the relatively high 
immunogenicity of antigens presented in immune-stimulating complexes (is- 
com). Their potency can in part be explained by the specific targeting of these 
structures to cells presenting antigens to the immune system. However, until now 
no method for the subcellular detection of iscom in situ was available. In the 
present study, a novel, fast and simple method for the detection of iscoms in situ is 
demonstrated. By making use of the lipophilic fluorescent carbocyanine dyes, 
1,l’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine p rchlorate (DiI) and 
3,3’-dioctadecyloxacarbocyanine perchlorate (DiO), rabies virus antigen and 
iscom prepared with this antigen were visualized with fluorescence microscopy. 
The labeled antigen and iscoms were observed in macrophages of spleen and liver 
of mice within 1-2 h after intravenous administration. When administered 
intramuscularly or in the footpad, uptake in macrophages of draining lymph 
nodes could be demonstrated. In the spleen, labeled inactivated virus antigen 
localized preferentially in the marginal zone macrophages and to a lesser extent in 
the red pulp macrophages. In contrast, antigen presented in iscom was taken up 
mainly by the marginal metallophilic macrophages and to a much lesser extend by 
marginal zone macrophages or follicular-dendritic and -B cells. This method 
enables the detection of iscom and membrane viruses and allows the analysis of 
their relation to antigen-presenting cells in situ. Here, we demonstrate that iscom 
containing rabies virus antigen are taken up by a subset of macrophages in the 
spleen distinct from those that take up inactivated rabies virus antigen not 
presented in iscom, thereby possibly explaining the observed difference in 
immunogenicity of these antigen preparations. Furthermore, we show a lower 
efficiency on the induction of humoral and cellular responses after intravenous 
immunization for both types of antigen when compared with subcutaneous 
immunization. 
1 Introduction 
Since immune-stimulating complexes (iscom) were initially 
described by Morein et al. [l], numerous studies have 
demonstrated their potential as a vaccine with built-in 
adjuvant properties. Bacterial, parasitic, viral and other 
proteins and peptides have been incorporated into iscom to 
enhance the immune response against these antigens [2]. 
Immunization with iscom generally induces both humoral 
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and cell-mediated immune responses [3]. The antibody 
responses against antigens incorporated in iscom are gen- 
erally higher and longer-lasting than those induced by the 
same amount of antigen not incorporated in this matrix. 
Furthermore, unlike most inactivated antigens, iscom can 
induce an MHC class-I-restricted cytotoxic T cell response 
specific for the immunizing antigen [4-61. Little is known 
about the early events after immunization with iscom, e.g. 
which antigen-presenting cells are involved or in which 
anatomical location (organ or compartment) the response 
is elicited. Watson et al. [7] described the inflammatory 
response and organ distribution of antigen after intraperi- 
toneal immunization with influenza virus glycoprotein in 
iscom or micelles using radioactively labeled antigens, and 
showed that the spleen is important in the uptake and 
retention of iscom. However, no detailed information on 
the involvement of splenic antigen-presenting cells (e.g. 
macrophages, dendritic cells, B cells) in the uptake, pro- 
cessing and presentation of iscom or inactivated virus is 
available. Such knowledge would allow the study of distinct 
subsets of antigen-presenting cells in the differential im- 
munogenicity of viral antigens presented in different ways. 
Here, we present a simple post-formation method for 
labeling virus and iscom by means of lipophilic fluorescent 
dyes. This method allows the study of virus and iscom 
distribution in the lymphoid organs at the cellular level. 
0014-29 8O/Y 5/05OS-1446$10.00 + .25/0 0 VCH Verlagsgesellschaft mbH, D-69451 Weinheim, 1995 
Eur. J. Immunol. 19%. 2.5: 1446-1452 Marginal mctallophilic macrophages and uptake o f  virus and iscom 1447 
2 Materials and methods 
2.1 Animals and chemicals 
Femalc BALB/c mice aged 12-16wceks, were kept in 
Macrolon cages under an 11-h dark/l3-h light regimen at 
20°C and were givcn acidified water (pH 3) and pelleted 
mouse food (Hope Farms, Woerden, The Netherlands) ad 
libitum. Di I (1,1f-dioctadecyl-3,3,3' , '-tetramethylindo- 
carbocyanine perchlorate; D-282), and DiO (3,3'-diocta- 
decyloxacarbocyanine perchlorate; D-275) were obtained 
from Molecular Probes (Eugene, OR). Monoclonal anti- 
bodies ERTR-9, specific for marginal zone macrophages, 
and MOMA-1, specific for marginal metallophillic macro- 
phages, were a kind gift of Prof. Dr. G.  Kraal, Frce 
University, Amsterdam, The Nctherlands. 
2.2 Antigens 
Rabies virus (RV-Pasteur stcain) was propagated in Vero 
cell monolayer cultures [8]. Culture supernatant was 
cleared by filtration and concentrated by Amicon ultrafil- 
tration (cut-off 106 Dalton). Virus was inactivated with 
[bpropiolactone (BPL) and stored at -70 "C at a conccn- 
tration of 900 pg/ml. This rabies virus antigen was used for 
the preparation of RV-iscom as described [9]. Briefly, RV 
proteins were solubilized with 10 % MEGA-10 (decanoyl- 
N-methylglucamide) for 2 h at room temperature. Thc 
solubilized virus was layered on top of a 10% sucrose 
cushion and centrifuged for 2 h at 200000 x g. Quil-A 
(Iscotec AB, LuleP, Sweden), cholesterol and phosphati- 
dylcholine (Sigma, St. Louis, MO) were added to the 
supernatant and the mixture dialyzed overnight against 
PBS. Frce Quil-A and unincorporated proteins were 
rcmovcd by centrifugation over a 20 sucrose cushion for 
48 11 at 150000 x g. Incorporation of RV proteins was 
aiialyzcd by SDS-PAGE and a glycoprotein-specific ELISA 
[lo]. 
2.3 Immunological responses and protection 
Immunological responses were measured 4 weeks after i.v. 
or S.C. immunization. RV-specific neutralizing antibody 
responses were measured by rapid fluorescence focus 
inhibition test (RFFIT) and T cell responses were meas- 
ured as described [11, 121. Briefly, spleen cells were isolated 
and stimulated with different concentrations of RV-BPL. 
After 5 days, cells were pulsed with L3H] thymidine for 
18 h. Cells were harvested on glass filters and incorporated 
radioactivity was measured in a Betaplate scintillation 
counter (LKB, Uppsala, Sweden). For protection studies, 
BALB/c mice were challenged intracerebrally with 30 LD5o 
rabies challenge virus standard CVS-26 according to stan- 
dard NIH potency testing of vaccines [13]. 
2.4 Fluorochrome labeling of RV antigen and RV-iscom 
Stock solutions of DiI and DiO were made in pure ethanol 
or DMSO (2.5 mg/ml). RV-BPL (100 pg), RV-iscom or 
cmpty iscom in I ml PBS were vigourously mixed with 8 pl 
(20 pg) DiI stock solution and incubated for 1 h at 37°C. 
Any unincorporated DiI formed crystals during this incu- 
bation period. After labeling, the samples were filtered 
using 0.45-pm filters to separate crystallinc DiI and labeled 
antigens [14]. Labeled material was stored in the dark at 
4°C for up to 4 weeks. 
Total amounts of carbocyanine label incorporated in virus 
and iscoms were determined with a Beckman DU-40 
UVlVis spectrophotometer. Wavclength scans were made 
from 380 to 600 nm with peaks at 552 nm for DiI and 
492 nm for DiO. Association of carbocyanine dye with thc 
iscom structure was demonstrated by purification of DiO- 
labeled iscom by density centrifugation on a 10-60 '3, 
sucrose gradient for 18 h at 40000 x g [IS].  
2.5 Fluorescence microscopy 
Frozen 8-pm sections of organs werc examined and photo- 
graphed directly after cryo-sectioning with an Olympus 
(Tokyo) VANOX fluorescence microscope. DiI fluores- 
cence was observed both as red with green light (excitation 
filter BP 54.5) and rhodamine/TRITC optics (emission: 
EO 570) and as golden-yellow with blue light (BP 
490 + EY 455) and FITC optics (EO 515). DiO fluores- 
cence was observed only with FITC optics as green 
(excitation: BP 490 + EY 455, cmission: EO 515). 
2.6 Enzyme- and immunocytochemistry 
Organ sections used for localization studies based on 
fluorescence microscopy were air-dried and fixed in 1% 
paraformaldehyde at 37°C for 15 min for simultaneous 
fluorescence and immunochemical detection (acetone dis- 
solves lipid membranes, causing a significant decrease in 
fluorescence of labeled iscom/virus). Sections for enzyme 
staining (nonspecific esterase; NSE) were fixed in acetone 
after fluorescence observation and photomicrography. 
Monoclonal antibody staining on fixed sections for margi- 
nal zone metallophilic macrophages (MOMA-1) was per- 
formed as described [16]. Endogenous acid phosphatase 
staining for the identification of all splenic and liver 
phagocytes and NSE staining for the detection of marginal 
metallophilic macrophages (MMM) was performed as 
described [16]. Localization of the respective subsets of 
splenic macrophages has also been described [17]. 
3 Results 
3.1 Incorporation of dyes in virus and iscom 
The efficiency of the labeling of viral antigen and iscom is 
shown in Fig. 1. At the optimal dye conccntration used 
(200 pg dye/mg iscom), up to 80% was integratcd in the 
RV-iscom. Under the same conditions, RV-BPL took up 
approximately 50% of the dye. The carbocyanine dye 
associates specifically with the iscom structure, as shown by 
sucrose gradient density centrifugation of DiO-labeled 
iscom and in a recent report dealing exclusively with 
mucosal localization of iscom [15]. To detcrmine whether 
the incorporation of these dyes influences the structure and 
immunological properties of iscom or viral antigcns, 
labeled antigens were analyzed morphologically by clcctron 
microscopy as well as for their immunogenicity in mice. 
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Figure 2. Electron micrographs ( X  106000) of unlabeled (left 
panel) and DiI-labeled (right panel) iscom matrix after 0.2-pm 
filtration: note no differences in typical cage-like iscom struc- 
ture. 
Fig. 2 shows representative electron micrographs of iscom 
matrix before (left panel) and after (right panel) DiI 
incorporation. No changes in the structure were observed 
aftcr DiI uptake, and all samples were devoid of any 
particulate material other than the iscom. Results obtained 
with RV-BPL (data not shown) were essentially the same as 
for RV-iscom. Labeled virus and iscoms were shown to 
retain their normal immunogenic properties (data not 
shown) as the same results were obtained as presented in 
Fig. 7 for non-labeled material. 
3.2 Localization of antigen and iscom in the spleen after 
i.p. or i.v. injection 
After i.p. and i.v. injection, both antigens could be 
demonstrated in the Kupffer cells of the liver within 15 min, 
shown, for iscom only, in Fig. 3a. No differences in liver 
localization pattern were observed between RV-BPL or 
RV-iscom. 
When DiI-labeled antigens were injected i.p. or i.v., uptake 
in splenic macrophages could be observed as early as 20 min 
after administration. Labeled RV-BPL preferentially local- 
ized in marginal zone macrophages (MZM) (Fig. 3b).When 
large amounts of RV-BPL were administered, antigen was 
also taken up by red pulp macrophages (RPM). Viral 
antigen was detected in roughly equal concentration ratios 
in MZM and RPM after 1-7 days irrespective of the dosage 
given. 
Labeled iscom were taken up by MZM as shown for other 
antigens. However, iscoms preferentially localized within 
MMM. As shown in Fig. 4, a section showing the uptake of 
DiI-labeled iscoms in the spleen was photographed 
(Fig. 4a) and subsequently fixed in acetone. Following 
fixation, the section was incubated with a substrate for 
NSE, an MMM endogenous enzyme marker (Fig. 4b). It is 
clear from these pictures that similar patterns are obtained 
for Dil-labeled iscoms and NSE activity. Although iscoms 
were not found exclusively in MMM, but also in MZM, 
almost all NSE-containing macrophages can be seen to 
have ingested iscoms, whereas RV-BPL could not be 
observed in these cells. 
The involvement of MMM in the uptake of iscom was also 
demonstrated by a double-fluorescence study. First, DiI- 
labeled iscom were injected in mice, and after 2 h the spleen 
was removed, frozen, cryo-sectioned and paraformalde- 
hyde-fixed. After fixation, sections were incubated with 
MOMA-1 antibody and goat anti-rat conjugated to FITC. 
Using FITC optics, DiI iscoms were observed as golden 
yellow and MOMA-1-staining cells as green. FITC did not 
fluoresce when using green light for excitation, showing 
iscom in red. Most MOMA-1 - positive cells were positive 
for DiI fluorescence, albeit with differences in intensity, 
and hence for iscom uptake (data not shown). 
Follicular localization (either on follicular-dendritic or 
-B cells) of iscom was also observed [green dots in F 
(follicle) Fig. 51 in a similar fashion as that shown for 
TNP-Ficoll [18] and for liposomes "1. 
3.3 Double-fluorescence labeling studies 
To confirm the differences in localization pattern of RV- 
BPL and RV-iscom, the following experiment was per- 
formed. RV-BPL was labeled with DiI and RV iscom with 
DiO. When observed using FITC optics, these labels 
fluoresce golden yellow for  RV-BPL and green yellow for 
iscom, respectively. Mixtures of these antigens were 
injected intravenously, and after 2 h, the spleens were 
removed. Observation of sections revealed that RV-BPL 
and iscom co-localized in MZM, but a small ring of cells on 
the border between marginal zone and periarteriolar 
lymphocyte sheath (PALS) contained only iscom (green 
yellow) and no labeled virus material (Fig. 5). 
3.4 Localization after intramuscular or subcutaneous 
injection 
When RV-BPL or RV-iscom were injected S.C. or i.m., both 
antigens were rapidly found in the draining lymph nodes. 
Figure 1 .  Incorporation of carbocyanine DiI in virus and iscom as 
determined by spectrophotometric measurements (wavelength 
scans from 390-600 nm) after 2 h incubation (see Sect. 2.4). 
Control 100 % contains the same amount of label as was added to 
the antigen preparations without filtration. Iscom, RV-BPL and 
PBS were all filtered to remove dye which was not take up in the 
lipid phasc after incubation. 
Figure 3. (a) Fluorescence microscopic image of an 8-pm liver cryo-section showing Dil-iscom localization in Kuppfer cells 2 h after 
intrapcritoneal injection. S = sinus. (b) Fluorescence microscopic image of an 8-pm spleen cryo-section showing localization of RV in a 
typical ring of MZM, 2 h after i.v. injection. 
Figure 5 .  This shows the different localization of DiI-labeled 
rabies virus (golden yellow) in MZM and DiO-labeled iscoms 
(green yellow) after i.v. injection. Two follicles (F) are segregated 
by the marginal zone. MMM are located on the border.The dashed 
line indicates the border between MMM and MZM. Also, follicular 
localization of the DiO-labeled iscoms (green spots) in the follicle 
can be seen. 
Figure 6. Fluorescence microscopic image of an 8-pm cryo-section 
showing DiI-iscom localization in the popliteal lymph node 2 h 
after S.C. injection in the footpad. 
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Intramuscular injection in the hind leg resulted in the 
uptake of both antigens in popliteal and inguinal lymph 
nodes. Footpad-injected antigens were found in the popli- 
teal lymph node only. In lymph nodes, labeled antigens 
localized initially in the subcapsular macrophages, and 
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after a few hours in the medullary macrophages. Localiza- 
tion is shown for s.c.-injected iscom only in Fig. 6. No 
differences between RV-BPL or RV-iscom localization 
patterns or intensity were observed. 
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Figure 4. (a) Fluorescence microscopic image of an 8-pm 
spleen cryo-section showing DiI-iscom loaclization 2 h after 
i.v. injection. (b) Shows the same section after acetone 
fixation and incubation with NSE substrate, specifically 
enzymatically staining the MMM. 
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Figure 7. (A) and (B) show the serum 
titer of RV-specific neutralizing antibod- 
ies 28 days after a single immunization 
with different antigens. (C) and (D) show 
RV-specific T cell responses of immune 
spleen cells when stimulated with 0.1 pg 
inactivated rabies virus in vitra. (E) and 
(F) show the percentage of survival fol- 
lowing challenge with 30 LDso live CVS- 
21 after a single immunization with differ- 
ent antigens. Virus neutralizing titers and 
T cell stimulation indices are mean values 
for at least three animals in a representa- 
tive experiment. Survival data after chal- 
lenge were determined in separate exper- 
iments. SC-RVBPL: BPL-inactivated RV 
given subcutaneously, SC-RVISC: RV 
iscom given s.c., SHAM: no immuniza- 
tion, IV-RVBPL: BPL-inactivated RV 
given i.v., IV-RVISC: RV iscom given 
i .v. 
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3.5 Immunological responses after immunization with 
RV-BPL and RV-iscom 
In vicw of the observed differences in localization patterns 
of KV-BPL and KV-iscom after i.v. and i.p. injection, mice 
were immunized to study the induction of B and T cell 
responses and protection against challenge with virulent 
RY The results, of which a representative experiment is 
shown in Fig. 7, showed that in mice, RV-iscom are about 
20-30-fold more potent than RV-BPL when injected 
subcutanously. RV-iscom and RV-BPL both induced good 
virus-neutralizing antibodies via both routes (Fig. 7A,B). 
Via the S.C. route, 0.08 yg RV-iscom induced RV-neutral- 
izing antibody titers as high as those found with 10 yg 
RV-BPL, demonstrating the higher immunogenicity of the 
RV-iscom. When administered i.v., comparable amounts of 
RV-iscom induced significantly lower titers. T cell prolif- 
eration in vitro after stimulation with RV-BPLwas used as a 
measure of T cell priming in vivo. Fig. 7C,D show that 
RV-iscom prime T cells more.efficiently and at lower doses 
than RV-BPL. Immunization doses as low as 0.08 pg 
RV-iscom still elicited T cell responses in vitro, and these 
data corresponded with the induction of neutralizing 
antibody titers. 
After intracerebral challenge with 30 LD5" CVS-26, all 
sham-treated animals (n  = 7) died (data not shown). Full 
protection was obtained with iscom with a dose as low as 
0.4 pg (n  = 6) when given via the subcutaneous route 
(Fig. 7E). RV-BPL was fully protective at a dose of 10 pg 
S.C. (Fig. 7F). When given intravenously, RV iscom were 
two- to fivefold less effcctive, but full protection could still 
bc obtained with 2 pg RV-iscom i.v. (n  = 3).Taken togeth- 
er, these data confirm the stronger immunogenicity of 
proteins incorporated into iscom, and also show a lower 
efficiency of the i.v. route of immunization over the S.C. 
route, especially for RV-iscom. 
4 Discussion 
RV-iscom, in contrast to inactivated RV antigen, are 
preferentially taken up by MMM of the murine spleen after 
i.v. or i.p. administration. This is an interesting finding 
since, until now, no involvement of this particular subset of 
macrophages in antigen uptake has been demonstrated. 
RV-iscom were more immunogenic than RV-BPL in terms 
of induction of virus-neutralizing antibodies, T cell res- 
ponses, and protection against disease. The subcutaneous 
immunization route, which primarily activates the draining 
lymph nodes, proved more efficient than immunization via 
the  i.v. route. Furthermore, it was shown that carbocyanine 
dyes can be used effectively to label membrane viruses and 
iscom, permitting localization pattern studies of these 
antigens in situ. 
DiI and DiO were taken up within a few seconds in viral 
membranes and iscom. The iscom matrix is highly hydro- 
phobic and membrane proteins are easily incorporated 
during its formation. Due to  this property and the lipophilic 
character of DiI and DiO, these dyes are easily incorpo- 
rated in the iscom structure. It should be stressed that these 
carbocyanine dyes are taken up exclusively in lipophilic 
structures, i.e. membranes, and, therefore, do not bind to  
or interfere with function or immunogenicity of surface 
proteins [14]. The use of antigens labeled in this way has 
enabled us to obtain data on the early processes of antigen 
handling in vivo. 
Recently, this method was used to study the kinetics of 
liposome uptake in which MZM and RPM play an impor- 
tant role [14]. In this study, it was surprising to find that 
there are indeed differences in the cell populations which 
are involved in uptake of the antigens when they enter the 
spleen. MZM are known to play an important role in the 
uptake of particulate antigens (t?.g. liposomes, bacteria) 
since they are among the first cells encountered upon entry 
in the spleen. 
Labeled RV and RV-iscom could be found in MZM within 
2 h after i.v. or i.p. injection, as would be expected. 
However, only iscom were found in MMM, a cell popula- 
tion which is located at the border of the marginal zone, 
characterized by slender processes protruding into the 
outer PALS, which is the main site of antibody production 
in the spleen. The role of these cells in the handling of 
antigens is unclear [20] but their involvement in the 
processing of antigens has been suggested by Kraal et al. 
[161. 
It should be noted that studies recently showed that 
selective uptake and retention of antigens by the MZM 
in vivo functions as a way of rapid antigen removal and 
elimination, thereby obscuring it from the immune system 
and hampering a normal response [21]. This may explain 
the relative inefficiency of RV-BPL taken up by MZM to 
induce immune responses at low doses, in contrast to results 
found with iscom, which are taken up by MMM. Similarly, 
the fact that significant amounts of both antigens given by 
the i.v. or i.p. route are taken up by the MZM could also 
explain the relative inefficiency of this route. 
The importance of the microenvironment for antigen 
processing and presentation in vivo has often been stressed 
[20, 221. From numerous studies, it is clear that extensive 
traffic and intimate contact of the cells in the spleen is 
necessary for the generation of the immune response. 
MZM degrade the entering antigens which are then 
transferred to secondarycells. It is not clear whether MMM 
behave differently from MZM in this respect. The strategic 
localization of MMM at the border of the marginal zone and 
close to the PALS (Fig. 4b) makes them ideal candidates 
for the transfer of antigens to antigen presenting B cells or 
perhaps interdigitating dendritic cells in the inner PALS. 
However, it is not clear which factor determines the specific 
uptake of iscom by MMM while other antigens, i.e. 
proteins, erythrocytes, bacteria or RV-BPL, are not found 
in this cell population. RV-iscom and empty iscom matrix 
localized in the same way. This finding demonstrates that 
the presence or absence of proteins in the iscom matrix does 
not influence localization behavior or the involvement of a 
particular subset of macrophages. Since low amounts of 
liposomes do not preferentially localize in MMM, a direct 
influence of cholesterol in this phenomenon can also be 
excluded, leaving Quil-A or the uncommon structure of the 
iscom as possible factors. 
The labeled iscom we detected in the splenic follicles within 
hours after administration could be indicative for comple- 
ment-mediated uptake [18] and a possible role for follicu- 
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lar-dendritic cells in antigen presentation. As reviewed by 
Kosco [23] follicular dendritic cells have the capacity to pass 
antigen to B cells which in turn are capable of processing 
and presenting it to Tcells, leading to germinal center 
formation [24]. On the other hand, macrophages can also 
efficiently present antigen to T cells, thereby functionally 
implicating subsets such as the MMM until proven other- 
wise, as it the case for the suppressive MZM. Notwithstand- 
ing the follicular localization of the iscoms, a role for 
follicular-dendritic or -B cells in the presentation and 
processing of iscom, which is also partly major histocom- 
patibility complex class I-dependent, remains to be proven. 
Until now, only one study has described the early events in 
the immune response following i.p. injections of iscoms 
compared to micelles. In this study, it was shown that there 
was a significant increase in the inflammatory response and 
an increase in the uptake of radiolabeled antigen in the 
spleen following immunization with iscom [7]. Even more 
interesting was the observation that a larger amount of 
antigen in iscom is retained in the spleen when compared to 
antigens in micelles. In the present study, fluorescence in 
spleen and lymph nodes could still be demonstrated after 
1 week, but not differences were observed between RV- 
BPL or iscom. 
In  conclusion, we have shown that macrophages from the 
marginal zone, and in particular the MMM, are involved in 
uptake and, therefore, probably also in processing and 
presentation of iscom-associated antigens. No evidence 
was found for direct interactions between iscom and T cells 
(iscom were not found in the main T cell areas). However, 
the follicular localization of iscom indicates direct activa- 
tion ofB cells, a not-unlikely mechanism in view of the fact 
that no differential macrophage localization was observed 
in the lymph nodes after S.C. or i.m. immunizations. 
Further studies, involving splenic macrophage elimination 
[25] to establish the role of MMM and MZM in the immune 
response against iscoms and viral antigens, are now under- 
way. 
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